Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Aphria Inc. > Nasdaq delisting schedule
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1830)
•••
Comment by DaveInCalgaryon Apr 30, 2021 1:29pm
247 Views
Post# 33102161

RE:Nasdaq delisting schedule

RE:Nasdaq delisting schedule
Friday, April 30, 2021
 
Equity Corporate Actions Alert #2021 - 71
Information Regarding the Merger of Aphria Inc. (APHA)
Category:
Industry Announcement
Markets Impacted:
The Nasdaq Stock Market
Contact Information:
Nasdaq Corporate Data Operations at
+1 877 308 0523
Nasdaq Trading Operations at
+1 212 231 5100
Resources
Press Release
At a special meeting held on April 14, 2021, shareholders of Aphria Inc. (APHA) approved the proposed merger with Tilray, Inc. (TLRY). The merger is anticipated to become effective today, April 30, 2021. The details are as follows:
 
Company/Issue: Aphria Inc. Common Shares
CUSIP#: 03765K104
Symbol: APHA
Anticipated Last Trading Date: April 30, 2021
Anticipated Marketplace Effective Date for Suspension: May 3, 2021
Merger Consideration: 0.8381 shares of Tilray for each share held.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities